TY - CONF T1 - Efficacy and safety of dupilumab in children aged >= 6 months to < 6 years with moderate-to-severe atopic dermatitis JO - BRITISH JOURNAL OF DERMATOLOGY PY - 2022/01/01 AU - Paller AS AU - Cork MJ AU - Siegfried EC AU - Simpson EL AU - Wollenberg A AU - Gonzalez ME AU - Sun Y AU - O'Malley JT AU - Bansal A ED - VL - 187 SP - 12 EP - 12 Y2 - 2025/04/10 ER -